Back to search
FDAFDA · Food and drugs·Recall number D-1031-2016

Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30.

Published June 22, 2016 · Recall initiated: May 19, 2016

Summary

FDA records drug Class III recall D-1031-2016, published June 22, 2016 and initiated May 19, 2016. Recalling firm: Galderma Laboratories, L.P.; Status: Terminated; Reported quantity: 71,340 Bottles; Lot: Lot #: 1496059A, Expiry: 08/31/2017; Lot #: AD9848A, Expiry: 11/30/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Galderma Laboratories, L.P.
Distributor
U.S. Nationwide
Lot
Lot #: 1496059A, Expiry: 08/31/2017; Lot #: AD9848A, Expiry: 11/30/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30. recalled?

Yes. FDA published recall D-1031-2016 on June 22, 2016. Reported hazard: Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter